South Korea
· Delayed Price · Currency is KRW Psomagen Statistics
Total Valuation
Psomagen has a market cap or net worth of KRW 79.83 billion. The enterprise value is 74.41 billion.
| Market Cap | 79.83B |
| Enterprise Value | 74.41B |
Important Dates
The next estimated earnings date is Friday, March 21, 2025.
| Earnings Date | Mar 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Psomagen has 19.24 million shares outstanding. The number of shares has decreased by -8.45% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 19.24M |
| Shares Change (YoY) | -8.45% |
| Shares Change (QoQ) | -21.15% |
| Owned by Insiders (%) | 20.31% |
| Owned by Institutions (%) | n/a |
| Float | 8.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.90 |
| PB Ratio | 2.77 |
| P/TBV Ratio | 3.72 |
| P/FCF Ratio | 62.06 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -12.33 |
| EV / Sales | 1.95 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 57.85 |
Financial Position
The company has a current ratio of 1.45, with a Debt / Equity ratio of 0.33.
| Current Ratio | 1.45 |
| Quick Ratio | 1.08 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | n/a |
| Debt / FCF | 7.42 |
| Interest Coverage | -27.59 |
Financial Efficiency
Return on equity (ROE) is -20.55% and return on invested capital (ROIC) is -9.64%.
| Return on Equity (ROE) | -20.55% |
| Return on Assets (ROA) | -7.41% |
| Return on Capital (ROIC) | -9.64% |
| Revenue Per Employee | 414.60M |
| Profits Per Employee | -65.60M |
| Employee Count | 89 |
| Asset Turnover | 0.75 |
| Inventory Turnover | 6.46 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.42% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -19.42% |
| 50-Day Moving Average | 4,222.40 |
| 200-Day Moving Average | 4,561.13 |
| Relative Strength Index (RSI) | 48.32 |
| Average Volume (20 Days) | 125,989 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Psomagen had revenue of KRW 38.14 billion and -6.04 billion in losses. Loss per share was -345.99.
| Revenue | 38.14B |
| Gross Profit | 7.79B |
| Operating Income | -6.05B |
| Pretax Income | -6.50B |
| Net Income | -6.04B |
| EBITDA | -1.72B |
| EBIT | -6.05B |
| Loss Per Share | -345.99 |
Balance Sheet
The company has 14.70 billion in cash and 9.55 billion in debt, giving a net cash position of 5.15 billion or 267.98 per share.
| Cash & Cash Equivalents | 14.70B |
| Total Debt | 9.55B |
| Net Cash | 5.15B |
| Net Cash Per Share | 267.98 |
| Equity (Book Value) | 28.52B |
| Book Value Per Share | 1,496.62 |
| Working Capital | 9.26B |
Cash Flow
In the last 12 months, operating cash flow was 4.80 billion and capital expenditures -3.51 billion, giving a free cash flow of 1.29 billion.
| Operating Cash Flow | 4.80B |
| Capital Expenditures | -3.51B |
| Free Cash Flow | 1.29B |
| FCF Per Share | 66.87 |
Margins
Gross margin is 20.42%, with operating and profit margins of -15.85% and -15.82%.
| Gross Margin | 20.42% |
| Operating Margin | -15.85% |
| Pretax Margin | -17.04% |
| Profit Margin | -15.82% |
| EBITDA Margin | -4.50% |
| EBIT Margin | -15.85% |
| FCF Margin | 3.37% |
Dividends & Yields
Psomagen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 8.45% |
| Shareholder Yield | 8.45% |
| Earnings Yield | -8.34% |
| FCF Yield | 1.61% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Psomagen has an Altman Z-Score of 0.6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.6 |
| Piotroski F-Score | n/a |